NFKB1 and Hyperammonemia: Yan et al. [32] revealed that the silencing receptor TLR5 can successfully alleviate oxidative stress and inflammation processes by inhibiting the MAPK/NF-κB signaling pathway in hyperammonemia-induced liver injury in vivo.